SLC35D2 (Hfrc): A Potential Drug Target (G11046)

Target Name: SLC35D2

NCBI ID: G11046

SLC35D2

SLC35D2 (Hfrc): A Potential Drug Target

SLC35D2 (Hfrc) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the sodium channel subfamily, which is a family of proteins that are involved in the transmission of electrical signals in the body.

SLC35D2 (Hfrc) has been identified as a potential drug target (or biomarker) due to its involvement in a variety of physiological processes, including the regulation of pain, inflammation, and neurotransmission.

One of the key functions of SLC35D2 (Hfrc) is its role in the regulation of pain. Pain is an unpleasant sensation that is often associated with injury or disease. The body's response to pain is a complex process that involves the transmission of electrical signals from the damaged tissue to the brain, which is then interpreted as pain. SLC35D2 (Hfrc) is involved in this process by helping to regulate the flow of calcium ions into the damaged tissue, which is believed to contribute to the sensation of pain.

SLC35D2 (Hfrc) is also involved in the regulation of inflammation. Inflammation is a natural response of the immune system to injury or infection, and it can cause a range of symptoms, including redness, swelling, and pain. SLC35D2 (Hfrc) is involved in the regulation of inflammation by helping to control the movement of immune cells into the site of injury or infection.

In addition to its role in pain and inflammation, SLC35D2 (Hfrc) is also involved in the regulation of neurotransmission. Neurotransmission is the process by which the brain communicates with other parts of the body, including the muscle, nerve, and endocrine system. SLC35D2 (Hfrc) is involved in this process by helping to regulate the release of chemical messengers called neurotransmitters from the endpoints of the synapses, which are the sites where nerve impulses are transmitted from one nerve cell to another.

SLC35D2 (Hfrc) is a transmembrane protein, which means that it spans the cell membrane and is involved in the regulation of various cellular processes that are located on the other side of the membrane. This makes it an attractive target for drug development because it is relatively easy to manipulate the activity of SLC35D2 (Hfrc) using drugs that can be administered through the bloodstream or other means.

In conclusion, SLC35D2 (Hfrc) is a protein that is involved in a variety of physiological processes in the body, including the regulation of pain, inflammation, and neurotransmission. As a result, it is a promising target for drug development due to its potential to contribute to the treatment of a wide range of diseases.

Protein Name: Solute Carrier Family 35 Member D2

Functions: Antiporter transporting nucleotide sugars such as UDP-N-acetylglucosamine (UDP-GlcNAc), UDP-glucose (UDP-Glc) and GDP-mannose (GDP-Man) pooled in the cytosol into the lumen of the Golgi in exchange for the corresponding nucleosides monophosphates (UMP for UDP-sugars and GMP for GDP-sugars). May take part in heparan sulfate synthesis by supplying UDP-Glc-NAc, the donor substrate, and thus be involved in growth factor signaling

The "SLC35D2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC35D2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets